Synchrony Medical Secures $5M to Bring Israeli-Developed Respiratory Device to More U.S. Patients
Israeli-U.S. Synchrony Medical secures $5M in funding to expand its FDA-cleared LibAirty respiratory device, developed in Israel, to more U.S. patients.